311 related articles for article (PubMed ID: 27756431)
1. The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden.
Sackey H; Hui M; Czene K; Verkooijen H; Edgren G; Frisell J; Hartman M
Breast Cancer Res; 2016 Oct; 18(1):105. PubMed ID: 27756431
[TBL] [Abstract][Full Text] [Related]
2. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
Wong SM; King T; Boileau JF; Barry WT; Golshan M
Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
[TBL] [Abstract][Full Text] [Related]
3. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
Ji J; Hemminki K
Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent risk of depression, anxiety, and stress-related disorders in patients with invasive and in situ breast cancer.
Yang H; Brand JS; Fang F; Chiesa F; Johansson AL; Hall P; Czene K
Int J Cancer; 2017 Feb; 140(4):841-852. PubMed ID: 27859142
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
6. Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992-2016.
Ramin C; Withrow DR; Davis Lynn BC; Gierach GL; Berrington de González A
Breast Cancer Res; 2021 Feb; 23(1):24. PubMed ID: 33596988
[TBL] [Abstract][Full Text] [Related]
7. Family History and Risk of Second Primary Breast Cancer after
Baglia ML; Tang MC; Malone KE; Porter P; Li CI
Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):315-320. PubMed ID: 29339357
[No Abstract] [Full Text] [Related]
8. Second cancers following in situ carcinoma of the breast.
Franceschi S; Levi F; La Vecchia C; Randimbison L; Te VC
Int J Cancer; 1998 Jul; 77(3):392-5. PubMed ID: 9663601
[TBL] [Abstract][Full Text] [Related]
9. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin.
Hemminki K; Dong C
Arch Dermatol; 2000 May; 136(5):647-51. PubMed ID: 10815858
[TBL] [Abstract][Full Text] [Related]
10. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
[TBL] [Abstract][Full Text] [Related]
11. Cause-specific mortality in women with breast cancer in situ.
He W; Sofie Lindström L; Hall P; Czene K
Int J Cancer; 2017 Jun; 140(11):2414-2421. PubMed ID: 27594272
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.
Wärnberg F; Bergh J; Zack M; Holmberg L
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):495-9. PubMed ID: 11352860
[TBL] [Abstract][Full Text] [Related]
13. Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain).
Molina-Montes E; Pollán M; Payer T; Molina E; Dávila-Arias C; Sánchez MJ
Gynecol Oncol; 2013 Aug; 130(2):340-5. PubMed ID: 23648471
[TBL] [Abstract][Full Text] [Related]
14. Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort.
Ramin C; Veiga LHS; Vo JB; Curtis RE; Bodelon C; Aiello Bowles EJ; Buist DSM; Weinmann S; Feigelson HS; Gierach GL; Berrington de Gonzalez A
Breast Cancer Res; 2023 May; 25(1):50. PubMed ID: 37138341
[TBL] [Abstract][Full Text] [Related]
15. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
16. Risk of second breast cancer according to estrogen receptor status and family history.
Bouchardy C; Benhamou S; Fioretta G; Verkooijen HM; Chappuis PO; Neyroud-Caspar I; Castiglione M; Vinh-Hung V; Vlastos G; Rapiti E
Breast Cancer Res Treat; 2011 May; 127(1):233-41. PubMed ID: 20878464
[TBL] [Abstract][Full Text] [Related]
17. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.
Schaapveld M; Visser O; Louwman WJ; Willemse PH; de Vries EG; van der Graaf WT; Otter R; Coebergh JW; van Leeuwen FE
Breast Cancer Res Treat; 2008 Jul; 110(1):189-97. PubMed ID: 17687645
[TBL] [Abstract][Full Text] [Related]
18. Second primary breast cancer occurrence according to hormone receptor status.
Kurian AW; McClure LA; John EM; Horn-Ross PL; Ford JM; Clarke CA
J Natl Cancer Inst; 2009 Aug; 101(15):1058-65. PubMed ID: 19590058
[TBL] [Abstract][Full Text] [Related]
19. Family history of breast or ovarian cancer modifies the risk of secondary leukemia after breast cancer: results from a population-based study.
Verkooijen HM; Fioretta G; Rapiti E; Vlastos G; Neyroud-Caspar I; Chappuis PO; Bouchardy C
Int J Cancer; 2008 Mar; 122(5):1114-7. PubMed ID: 17973260
[TBL] [Abstract][Full Text] [Related]
20. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
Gao X; Fisher SG; Emami B
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1038-45. PubMed ID: 12829139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]